Preparation of solid inclusion complex of deoxypodophyllotoxin - SBE-β-CD and its antitumor activity

Journal of China Pharmaceutical University

Volumn 41, Issue 5, 2010, Pages 447-450

  Zhu, Xiong ^a   Wu, Bao Jin ^a   Luo, Hou Wei ^a   Tao, Lei ^a   Zhao, Qing ^a   Guo, Qing Long ^a   Wu, Chang Xuan ^b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b Nanjing Lifenegry R and D Co Ltd   (China)

Author keywords

cyclodextrin; Antitumor activity; Deoxypodophyllotoxin; Inclusion complex; Sulphobutyl ether

Indexed keywords

DEOXYPODOPHYLLOTOXIN; SULPHOBUTYL ETHER BETA CYCLODEXTRIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; DIFFERENTIAL SCANNING CALORIMETRY; DRUG SOLUBILITY; IN VITRO STUDY; IN VIVO STUDY; X RAY DIFFRACTION;

EID: 78650721191     PISSN: 10005048     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Gordaliza M, Castro MA, García-Grávalos MD, et al. Antineoplastic and antiviral activities of podophyllotoxin related lignans [J]. Arch Pharm, 1994, 327 (3): 175-179. (Pubitemid 24092622)
2. San Feliciano A, Gordaliza M, Miguel del Corral JM, et al. An tineoplastic and antiviral activities of some cyclolignans [J]. Planta Med, 1993, 59 (3): 246-249. (Pubitemid 23168772)
3. Heim R. Tsien RY. Engineering green fluorescent protein for improved brightness, longer wavelengths and fluorescence resonance energy transfer[J]. Curr Biol, 1996, 6 (2): 178-182. (Pubitemid 2616642)
4. Tian H, Ip L, Lu o H, et al. A high throughput drug screen based on fluorescence resonance energy transfer( FRET) for anticancer activity of compounds from herbal medicine [J]. Br J Pharmacol, 2007, 150 (3): 321-334. (Pubitemid 46221041)
5. Gu FG, Gao YL, Cui FD. [J]. Chin New Drugs J, 2004, 13 (1): 15-19.
6. Sweden approves antipsychotic Zeldox ( ziprasidone ), intramuscular formulation [EB/OL]. [2000-09-05]. http://www.pslgroup.com/dg/1dfc52.htm.
7. FDA psychopharmacological drugs advisory committee, briefing documet for ziprasidone mesylate for intramuscular injection [EB/OL]. [2001-02-15]. http://www.fda.gov/ohrms/ dockets/ac/01/briefing/3685b2-01-pfizer.pdf.
8. Wang W, Guo QL, You QD, et al. The anticancer activities of wogonin in murine sarcoma S180 both in vitro and in vivo[J]. Biol Pharm Bull, 2006, 29(6):1 132-1 137.